BioProtect bioprotect.co.il


Public lists: Medical Devices (6123)

BioProtect has developed a minimally invasive, biodegradable, biological balloon implant which reduces rectal toxicity in prostate cancer radiation therapy.

BioProtect has developed a minimally invasive, biodegradable, biological balloon implant which reduces rectal toxicity in prostate cancer radiation therapy.

Company (Alive / Active)

Phone: +972-9-7731929

Fax:

21 Atir Yeda St.

Kfar Saba, 44643
Israel

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
BioProtect $4.3M Apr 13, 2017
See all 18 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related BioProtect Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Gynesonics

Redwood City, California, United States
Alive / ActiveGynesonics is a women's healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids. Gynesonics has developed the Sonata System for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance. The Sonata System, the next generation of Gynesonics' technology platform (the previous generation referred to as VizAblate), uses radiofrequency energy to ablate fibroids under intrauterine sonography guidance. The Sonata System, inclu...Show allLogin to see details

Axial Biotech

Salt Lake City, Utah, United States
Alive / ActiveAxial Biotech, founded in 2002 by a group of spine surgeons and geneticists, is focused on the use of genetics and the development of minimally invasive fusionless devices to advance the diagnosis and treatment of diseases and deformities of the human spine. Axial is a company to pursue DNA-based pre-symptomatic and prognostic tests for common spinal conditions which will augment current clinical and surgical practices. In its initial genetic product development initiative, Axial has made progre...Show allLogin to see details
See all 18 competitors